{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:46:23Z","timestamp":1768801583076,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T00:00:00Z","timestamp":1299456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00066-011-2252-4","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T16:03:14Z","timestamp":1300464194000},"page":"221-224","source":"Crossref","is-referenced-by-count":19,"title":["Radiotherapy of splenomegaly","Radiotherapie der Splenomegalie. Eine palliative Behandlungsmodalit\u00e4t eines benignen Symptoms bei h\u00e4matoonkologischen Erkrankungen"],"prefix":"10.1007","volume":"187","author":[{"given":"Jan","family":"Kriz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Micke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Haverkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Seegenschmiedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf-Peter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Theodor","family":"Eich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,7]]},"reference":[{"key":"2252_CR1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.7326\/0003-4819-116-12-977","volume":"116","author":"D. Calverly","year":"1992","unstructured":"Calverly D, Jones G, Kelton J. Splenic radiation for corticosteroid-resistant immune thrombocytopenia. Ann Intern Med 1992;116:977\u201381.","journal-title":"Ann Intern Med"},{"key":"2252_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00066-008-1807-5","volume":"184","author":"W. D\u00f6rr","year":"2008","unstructured":"D\u00f6rr W, Herrmann T. Second tumors after oncologic treatment. Strahlenther Onkol 2008;184:67\u201372.","journal-title":"Strahlenther Onkol"},{"key":"2252_CR3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00066-009-1937-4","volume":"185","author":"H.T. Eich","year":"2009","unstructured":"Eich HT, Heimann M, Kriz J et al. Long term outcome and prognostic factors in early stage nodal low-grade non Hodgkin\u2019s lymphoma treated with radiotherapy. Strahlenther Onkol 2009;185:288\u201395.","journal-title":"Strahlenther Onkol"},{"key":"2252_CR4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00066-008-1882-7","volume":"184","author":"H.T. Eich","year":"2008","unstructured":"Eich HT, M\u00fcller R-P, Engenhart-Cabillic R et al (2008) Involved node radiotherapy in early-stage Hodgkin\u2019s lymphoma \u2014 definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 184:406\u201310.","journal-title":"Strahlenther Onkol"},{"key":"2252_CR5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","volume":"103","author":"M.A. Elliot","year":"1998","unstructured":"Elliot MA, Chen MG Silverstein MN et al. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Haematol 1998;103:505\u201311.","journal-title":"Br J Haematol"},{"key":"2252_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1054\/blre.1999.0110","volume":"13","author":"M.A. Elliot","year":"1999","unstructured":"Elliot MA, Tefferi A. Splenic irradiation in myelofibrosis with myeloid metaplasia a review. Blood Rev 1999;13:163\u201370.","journal-title":"Blood Rev"},{"key":"2252_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00066-010-2144-z","volume":"186","author":"M. Guckenberger","year":"2010","unstructured":"Guckenberger M, OK S, Polat B et al. Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 2010;186:535\u201343.","journal-title":"Strahlenther Onkol"},{"key":"2252_CR8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0360-3016(77)90113-4","volume":"2","author":"J.S. Greenberg","year":"1977","unstructured":"Greenberg JS, Chaffey JT, Rosenthal DS et al. Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasia. Int J radiat Oncol Biol Phys 1977;2:1083\u201390.","journal-title":"Int J radiat Oncol Biol Phys"},{"key":"2252_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0360-3016(89)90035-7","volume":"16","author":"M.J. Guiney","year":"1988","unstructured":"Guiney MJ. A study of splenic irradiation in chronic lymphocytic leukemia. Int J Radiat Oncol Biol Phys 1988;16:225\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2252_CR10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00066-010-2132-3","volume":"86","author":"J. Kopecky","year":"2010","unstructured":"Kopecky J, Priester P, Slovacek L et al. Aplastic anaemia as a cause of death in a patient with glioblastoma multiforme treated with temozolomide. Starhlenther Onkol 2010;86:452\u20137.","journal-title":"Starhlenther Onkol"},{"key":"2252_CR11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/bjs.1800730915","volume":"73","author":"J. Malmeus","year":"1986","unstructured":"Malmeus J, Akre T, Adami HO et al. Early postoperative course following elective splenectomy in hematological diseases: a high complication rate in patients with myeloproliferative disorders. Br J Surg 1986;73:720\u20133.","journal-title":"Br J Surg"},{"key":"2252_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000421-200304000-00016","volume":"26","author":"J.T. McFarland","year":"2003","unstructured":"McFarland JT, Kuzma C, Millard et al. Palliative irradiation of the spleen. Am J Clin Oncol 2003;26:178\u201383.","journal-title":"Am J Clin Oncol"},{"issue":"Suppl1","key":"2252_CR13","first-page":"347a","volume":"90","author":"R.A. Mesa","year":"1997","unstructured":"Mesa RA, Tefferi A, Jacobsen SJ et al. The incidence and epidemiology of essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study (Abstract). Blood 1997;90(Suppl 1):347a. sai]14._Mesa RA. How I treat symptomatic splenomegaly in patients with myelofibrosis. Blood 2009;113:5394\u2013400.","journal-title":"Blood"},{"key":"2252_CR14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0360-3016(77)90112-2","volume":"2","author":"C. Parmentier","year":"1977","unstructured":"Parmentier C, Charbord P, Tibi M et al. Splenic irradiation in myelofibrosis. Clinical findings and ferrokinetics. Int J Radiat Oncol Biol Phys 1977;2:1075\u201381.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2252_CR15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00066-010-2141-2","volume":"186","author":"M. Portaluri","year":"2010","unstructured":"Portaluri M, Fucilli F, Gianicolo E et al. Collection and evaluation of incidents in a radiotherapy department: a reactive risk analysis. Strahlenther Onkol 2010;186:693\u20139.","journal-title":"Strahlenther Onkol"},{"key":"2252_CR16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s00066-010-2158-6","volume":"186","author":"J. Cla\u00dfen","year":"2010","unstructured":"Cla\u00dfen J, Nitzsche S, Wallwiener D et al. Fibrotic changes after postmastectomy radiotherapy and reconstructive surgery in breast cancer. A retrospective analysis in 109 patients. Strahlenther Onkol 2010;186:630\u20136.","journal-title":"Strahlenther Onkol"},{"key":"2252_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000069859","volume":"26","author":"A.U. Schratter-Sehn","year":"2003","unstructured":"Schratter-Sehn AU, Cerveny M, Simmel H et al. Short-time splenic irradiation for splenomegaly. Onkologie 2003;26:21\u20134.","journal-title":"Onkologie"},{"key":"2252_CR18","first-page":"281","volume":"63","author":"N. Senn","year":"1903","unstructured":"Senn N. Case of spleno-medullary leukemia successfully treated by use of roentgen ray. Med Rec New York 1903;63:281.","journal-title":"Med Rec New York"},{"key":"2252_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1673.2008.01958.x","volume":"52","author":"R.K. Shrimali","year":"2008","unstructured":"Shrimali RK, Correa PD, O\u2019Rourke N. Low-dose palliative splenic irradiation in haematolymphoid malignancy. J Med Imaging Radiat Oncol 2008;52: 297\u2013302.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2252_CR20","first-page":"682","volume-title":"Harrison\u2019s principles of internal medicine","author":"J. Spivak","year":"1998","unstructured":"Spivak J. Idiopathic myelofibrosis. In: Harrison\u2019s principles of internal medicine. San Francisco: McGraw-Hill 1998:682."},{"key":"2252_CR21","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1097-0142(19860915)58:6<1204::AID-CNCR2820580605>3.0.CO;2-G","volume":"58","author":"H. Wagner Jr","year":"1986","unstructured":"Wagner H Jr, McKeough PG, Desforges J et al. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittend fraction with or without concomitant hydoxyurea. Cancer 1986;58:1204\u20137.","journal-title":"Cancer"},{"key":"2252_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0167-8140(00)00316-9","volume":"58","author":"M. Weinmann","year":"2001","unstructured":"Weinmann M, Becker G, Einsele H et al. Clinical indications and biological mechanisms of splenic irradiation in chronic leukemias and myeloproliverative disordes. Radiother Oncol 2001;58:235\u201346.","journal-title":"Radiother Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-011-2252-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-011-2252-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-011-2252-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:31:04Z","timestamp":1558578664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-011-2252-4"}},"subtitle":["A palliative treatment option for a benign phenomenon in malignant diseases"],"short-title":[],"issued":{"date-parts":[[2011,3,7]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["2252"],"URL":"https:\/\/doi.org\/10.1007\/s00066-011-2252-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,7]]}}}